Projects per year
Search results
-
Finished
Defining the nature of the myeloid contexture according to metastatic site in colorectal cancer
Middleton, G. (Principal Investigator)
7/03/22 → 31/03/23
Project: Research
-
MHC Class II expression in MSS (non-MHC Class II inducible) colorectal cancer
Middleton, G. (Co-Investigator) & Beggs, A. (Principal Investigator)
CANCER RESEARCH TECHNOLOGY LTD
1/05/21 → 9/09/22
Project: Industry
-
The Identification of Novel Therapy Options in Difficult to Treat Non-Small Cell Lung Cancer (INTO-Lung Cancer)
Middleton, G. (Principal Investigator) & Beggs, A. (Co-Investigator)
1/10/20 → 30/09/23
Project: Research
-
Functional genomics of aneuploidy in Oesophageal Adenocarcinoma
Middleton, G. (Co-Investigator), Contino, G. (Principal Investigator) & Beggs, A. (Co-Investigator)
1/09/20 → 31/08/24
Project: Research
-
CATALYST: A randomised early phase adaptive trial for new drugs for SARS-CoV-2+ patients
Gates, S. (Co-Investigator), Parekh, D. (Co-Investigator), Bowden, S. (Co-Investigator), Kearns, P. (Principal Investigator), Bion, J. (Co-Investigator), Slade, D. (Co-Investigator), Middleton, G. (Co-Investigator), Patel, J. (Co-Investigator), Thickett, D. (Co-Investigator), Fisher, B. (Co-Investigator), Newsome, P. (Researcher), Gao Smith, F. (Co-Investigator), Rowe, A. (Co-Investigator), Sharpe, R. (Co-Investigator), Mussai, F. (Co-Investigator) & Sapey, E. (Co-Investigator)
1/06/20 → 31/05/21
Project: Research Councils
-
A phase II trial to assess the activity of Gemtuzumab Ozogamicin Therapy in HAemophagocytic lymphohistiocytosis (HLH) or Macrophage activation syndrome (MAS) or relapsed/refractory solid tumours
De Santo, C. (Co-Investigator), Kearns, P. (Co-Investigator), Billingham, L. (Co-Investigator), Middleton, G. (Principal Investigator) & Mussai, F. (Co-Investigator)
Little Princess Trust, Eveson Charitable Trust
1/01/20 → 31/12/24
Project: Research
-
Identification of genetic factors that predispose to either immune checkpoint inhibitor or conventional chemotherapy toxicity
Palles, C. (Principal Investigator), Middleton, G. (Co-Investigator) & Steven, N. (Co-Investigator)
1/10/19 → 31/12/24
Project: Research
-
The Birmingham CRUK Centre Clinical Academic Training Programme
Middleton, G. (Principal Investigator), Brain, K. (Co-Investigator), Thomas, K. (Co-Investigator), Sundar, S. (Co-Investigator), Harper, L. (Co-Investigator) & Tennant, D. (Co-Investigator)
1/10/19 → 31/12/24
Project: Research
-
BHP Starter Fellowship - Toritseju Sillo
Middleton, G. (Principal Investigator)
1/10/19 → 30/09/20
Project: Research
-
IMMUNE GENE EXPRESSION AND NEOANTIGEN CLONALITY IN COLORECTAL CANCER
Yau, C. (Co-Investigator), Beggs, A. (Co-Investigator) & Middleton, G. (Principal Investigator)
BOWEL DISEASE RESEARCH FOUNDATION
29/04/19 → 29/04/21
Project: Research
-
Is B cell Immune phenotype predictive of outcome and toxicity with combination checkpoint blockade in Non-small cell lung cancer patients
Patel, A. (Principal Investigator) & Middleton, G. (Co-Investigator)
1/02/19 → 31/01/21
Project: Research
-
Tracer X - Fellowship
Naidu, B. (Principal Investigator) & Middleton, G. (Co-Investigator)
31/03/18 → 30/06/20
Project: Research
-
Amendment for the National Lung Matrix Trial: Multi-drug, genetic marker-directed, non-comparative, multi-centre, multi-arm phase II trial in non-small cell lung cancer
Steven, N. (Co-Investigator), Middleton, G. (Principal Investigator) & Billingham, L. (Co-Investigator)
1/10/17 → 31/03/19
Project: Research
-
Clinical Training Award Cycle 3 2017
Middleton, G. (Principal Investigator)
1/09/17 → 31/12/22
Project: Research
-
Understanding the molecular basis and consequences of chemoradiosensitivity in rectal cancer in order to improve tharapy (MOL-RSRC)
Middleton, G. (Co-Investigator), Cazier, J.-B. (Co-Investigator) & Beggs, A. (Principal Investigator)
3/04/17 → 31/03/22
Project: Research
-
Birmingham ECMC
Beggs, A. (Co-Investigator), Moss, P. (Co-Investigator), Kearns, P. (Co-Investigator), Craddock, C. (Co-Investigator), Nankivell, P. (Co-Investigator), Willcox, B. (Co-Investigator), Morton, D. (Co-Investigator), Middleton, G. (Principal Investigator), Khoja, L. (Researcher), Drayson, M. (Co-Investigator), Tomlinson, I. (Co-Investigator), Steven, N. (Co-Investigator), Taylor, M. (Co-Investigator), Watts, C. (Co-Investigator) & Mehanna, H. (Co-Investigator)
1/04/17 → 31/03/23
Project: Research
-
Cancer Research UK Birmingham Centre. See Also RCPV20624
Kearns, P. (Co-Investigator), Willcox, B. (Principal Investigator), Lee, S. (Co-Investigator), Middleton, G. (Co-Investigator), Moss, P. (Co-Investigator) & Morton, D. (Co-Investigator)
1/04/17 → 31/12/24
Project: Research
-
Study the mechanisms in BRAF mutant colorectal cancer (CRC) cells treated with PLX8394
Middleton, G. (Principal Investigator)
25/08/16 → 30/09/23
Project: Research
-
A comparison of the immunological microenvironment of primary and pulmonary metastic colorectal cancer.
Willcox, B. (Principal Investigator) & Middleton, G. (Co-Investigator)
1/07/16 → 31/10/17
Project: Research
-
From immune suppression to immunotherapy: the function and clinical significance of the immune response to pancreatic cancer
Moss, P. (Principal Investigator), Middleton, G. (Co-Investigator) & Cazier, J.-B. (Co-Investigator)
1/07/16 → 31/01/23
Project: Research
-
Understanding the cells that supress the immune system in patients with malignant pleural mesothelioma and investigating treatments to target these cells
Middleton, G. (Principal Investigator)
1/04/16 → 31/12/19
Project: Research
-
RUXSAC -A double blind, placebo-controlled, randomized phase II study of Pemetrexed and Cisplatin with and without Ruxolitinib in Malignant Pleural Mesothelioma.
De Santo, C. (Co-Investigator), Billingham, L. (Co-Investigator), Mussai, F. (Co-Investigator) & Middleton, G. (Principal Investigator)
NOVARTIS PHARMACEUTICALS UK LTD, NIHR
17/12/15 → 31/12/20
Project: Research
-
A phase II trial of MK-3475 in patients with non-small cell lung cancer with a performance status of 2 (PePS2)
Billingham, L. (Co-Investigator) & Middleton, G. (Principal Investigator)
21/10/15 → 31/12/24
Project: Industry
-
Understanding the role of myeloid derived suppressor cells (MDSCs) in the immune microenvironment of malignant pleural mesothelioma an targeting the effects of clinical JAK2/STAT3 inhibition on their number and function
Middleton, G. (Principal Investigator)
THE JUNE HANCOCK MESOTHELIOMA RESEARCH FUND
1/03/15 → 28/02/18
Project: Research
-
Stratified Medicene Matrix Trial
Middleton, G. (Principal Investigator), Billingham, L. (Co-Investigator) & Steven, N. (Co-Investigator)
Cancer Research Uk, INIVATA LTD, ASTRA ZENECA UK LIMITED
1/08/14 → 31/10/21
Project: Research
-
Stratified Medicine:Methods for Evaluating Predictive Biomarkers for Treatment of Cancer
Billingham, L. (Principal Investigator), Deeks, J. (Co-Investigator), Riley, R. (Co-Investigator), Craddock, C. (Co-Investigator), Middleton, G. (Co-Investigator) & Morton, D. (Co-Investigator)
1/06/14 → 31/05/17
Project: Research
-
Tracking Cancer Evolution through Therapy (Tracer X)
Middleton, G. (Principal Investigator) & Naidu, B. (Co-Investigator)
1/01/14 → 31/12/22
Project: Research
-
Quantification and functional consequences of TTN mutations in human colorectal cancer
Middleton, G. (Principal Investigator)
1/07/13 → 31/03/14
Project: Research
-
Molecular selection of therapy in metastatic colorectal cancer: a molecularly stratified randomised controlled trial programme (FOCUS 4)
Middleton, G. (Principal Investigator)
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/04/13 → 31/03/20
Project: Other Government Departments
-
(60MTHS)Renewal of ECMC at Birmingham
Tselepis, C. (Co-Investigator), Middleton, G. (Co-Investigator), Craddock, C. (Co-Investigator), Moss, P. (Co-Investigator), Steven, N. (Co-Investigator) & Morton, D. (Principal Investigator)
1/04/12 → 31/03/17
Project: Research